Differences in checkpointinhibitor- induced hypophysitis: mono- versus combination therapy induced hypophysitis.

MLA

van der Leij, Stephanie, et al. “Differences in Checkpointinhibitor- Induced Hypophysitis: Mono- versus Combination Therapy Induced Hypophysitis.” Frontiers in Endocrinology, Aug. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fendo.2024.1400841.

APA

van der Leij, S., Suijkerbuijk, K. P. M., den Broek, M. F. M. van, Valk, G. D., Dankbaa, J. W., & van Santen, H. M. (2024). Differences in checkpointinhibitor- induced hypophysitis: mono- versus combination therapy induced hypophysitis. Frontiers in Endocrinology, 1–9. https://doi.org/10.3389/fendo.2024.1400841

Chicago

van der Leij, Stephanie, Karijn P. M. Suijkerbuijk, Medard F. M. van den Broek, Gerlof D. Valk, Jan Willem Dankbaa, and Hanneke M. van Santen. 2024. “Differences in Checkpointinhibitor- Induced Hypophysitis: Mono- versus Combination Therapy Induced Hypophysitis.” Frontiers in Endocrinology, August, 1–9. doi:10.3389/fendo.2024.1400841.